You are here

HHS

Former BARDA director claims HHS leaders tried to 'thwart' him in new role

Former BARDA director claims HHS leaders tried to 'thwart' him in new role

BioPharma Dive

Flag link:

Trump administration fires back at ousted vaccine expert as he testifies on his role in U.S. coronavirus response

Trump administration fires back at ousted vaccine expert as he testifies on his role in U.S. coronavirus response

Stat

Flag link:

U.S. health agency to fund two diagnostic tests for coronavirus

U.S. health agency to fund two diagnostic tests for coronavirus

Reuters

Diasorin Molecular

Flag link:

Court Determines that Decade’s Worth of Missing Data Must Be Published on ClinicalTrials.gov but Enforcement of Reporting Violations Hinges on FDA Discretion

Court Determines that Decade’s Worth of Missing Data Must Be Published on ClinicalTrials.gov but Enforcement of Reporting Violations Hinges on FDA Discretion

FDA Law Blog

clinical trials

clinical trial data

clinical trial transparency

Flag link:

OIG Finds Most Drugs can be Traced Through Supply Chain Thanks to DSCSA

OIG Finds Most Drugs can be Traced Through Supply Chain Thanks to DSCSA

RAPS.org

Flag link:

Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court

Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court

Fierce Pharma

Gilead Sciences

Flag link:

Sanofi announces it will work with HHS to develop coronavirus vaccine

Sanofi announces it will work with HHS to develop coronavirus vaccine

Stat

Flag link:

Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development

Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development

Motley Fool

Flag link:

Trump’s 2021 budget request seeks modest funding increase for FDA

Trump’s 2021 budget request seeks modest funding increase for FDA

Endpoints

Flag link:

Gilead loses first PrEP patent challenge but vows to defend against HHS lawsuit

Gilead loses first PrEP patent challenge but vows to defend against HHS lawsuit

Fierce Pharma

Gilead Sciences

Flag link:

Drugmaker Regeneron working with U.S. HHS to develop coronavirus treatment

Drugmaker Regeneron working with U.S. HHS to develop coronavirus treatment

Reuters

Wuhan Coronavirus

Flag link:

Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads

Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads

Fierce Pharma

Flag link:

HHS Pays For PrEP But Who Will Prescribe It?

HHS Pays For PrEP But Who Will Prescribe It?

Forbes

Flag link:

HHS to probe whether Google’s ‘Project Nightingale’ followed federal privacy law

HHS to probe whether Google’s ‘Project Nightingale’ followed federal privacy law

Stat

Project Nightingale

Flag link:

HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills

HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills

Stat

Gilead Sciences

Flag link:

Device Industry Backs Proposed Changes to Anti-Kickback Statute, Stark Law

Device Industry Backs Proposed Changes to Anti-Kickback Statute, Stark Law

RAPS.org

Flag link:

HHS pledges $23M to develop Merck's experimental Ebola vaccine

HHS pledges $23M to develop Merck's experimental Ebola vaccine

Beckers Hospital Review

Flag link:

Six Reasons Why the Rebate Rule Failed—And What’s Next

Six Reasons Why the Rebate Rule Failed—And What’s Next

Drug Channels

Flag link:

Azar's Plan To Tie U.S. Drug Prices To Foreign Ones Will Impact Investments In R&D

Azar's Plan To Tie U.S. Drug Prices To Foreign Ones Will Impact Investments In R&D

Forbes

Flag link:

Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads

Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads

BioCentury

Flag link:

Pages